Charlotte Teunissen highlights some of the research presented on AD biomarkers, including a novel assay for multiphosphorylated tau and the impact of confounding factors.
Charlotte Teunissen highlights some of the research presented on AD biomarkers, including a novel assay for multiphosphorylated tau and the impact of confounding factors.
Contact us: ime@springer.com
This activity is supported by an educational grant from Lilly.
This content was last updated on 3rd March 2024
Follow Us:
Manage cookie preferences
© 2024 Springer Healthcare Ltd | Website by Arttia Creative
